U.S., April 15 -- ClinicalTrials.gov registry received information related to the study (NCT06926660) titled 'A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease' on April 11.
Brief Summary: This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication for kidney disease called SGLT2 inhibitor within 1 month before the study or have certain health conditions cannot take part in this study. The purpose of this study is to find out whether a medicine called vicadrostat, used in combination with another medicine called empagliflozin, works in people with chronic kidney disease.
In this study, parti...